CYBERDYNE Inc. (TYO:7779)
241.00
-2.00 (-0.82%)
Jan 21, 2026, 1:25 PM JST
CYBERDYNE Revenue
CYBERDYNE had revenue of 963.00M JPY in the quarter ending September 30, 2025, a decrease of -2.53%. This brings the company's revenue in the last twelve months to 4.20B, down -4.30% year-over-year. In the fiscal year ending March 31, 2025, CYBERDYNE had annual revenue of 4.38B with 0.69% growth.
Revenue (ttm)
4.20B
Revenue Growth
-4.30%
P/S Ratio
12.20
Revenue / Employee
19.92M
Employees
211
Market Cap
51.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.38B | 30.00M | 0.69% |
| Mar 31, 2024 | 4.35B | 1.07B | 32.38% |
| Mar 31, 2023 | 3.29B | 1.14B | 52.98% |
| Mar 31, 2022 | 2.15B | 275.00M | 14.67% |
| Mar 31, 2021 | 1.88B | 83.00M | 4.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |